News
A rare gastrointestinal cancer is rising sharply among Gen X and Millennials, prompting experts to call for more research.
22h
Everyday Health on MSNAppendix Cancer Sharply Rises Among Gen Xers, MillennialsExperts worry about the uptick in cases as more Gen Xers and millennials are being diagnosed with a variety of ...
Appendix cancer is a condition that, until recently, was so rare that most people never gave it a second thought. For decades ...
Apollo Cancer Centre, Chennai introduces robotic pancreatic surgery program for complex surgeries, ensuring precision, ...
Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors and were among the first solid tumor types for which such a novel treatment (in this case imatinib) became available. The ...
CANCER is typically thought of as a disease of old age. But doctors are increasingly finding that certain types, particularly ...
Rates of appendiceal adenocarcinoma more than tripled among Americans born in 1980 compared with those born in 1945, a study ...
To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of ...
Though extremely rare, cancers of the appendix are being diagnosed at higher rates in Gen X and millennials compared with ...
Katie Couric, popularly known for hosting NBC’s Today show, paid tribute to her late husband on what would have been the couple’s 36th wedding anniversary.
The FDA has approved a revised label for Merck’s immunotherapy drug Keytruda, limiting its use in some gastrointestinal cancer treatments to patients whose tumors express a minimum level of PD-L1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results